The market seems to go up, mainly based on the merger with Qualigen - ( I did not find any other news regarding this stock)
Qualigen should become a wholly-owned subsidiary of Ritter.
Upon completion of the merger, Ritter will change its name to Qualigen Therapeutics, Inc., and will focus on the development of Qualigen’s nanotechnology therapies for the...
